Kezar Life Sciences Announces 1-For-10 Reverse Stock Split, Will Begin Trading On A Post-Split Basis At The Market Open On October 30, 2024
Portfolio Pulse from Benzinga Newsdesk
Kezar Life Sciences (NASDAQ:KZR) will implement a 1-for-10 reverse stock split effective October 29, 2024, to comply with Nasdaq's minimum bid price requirement. Trading on a post-split basis will begin on October 30, 2024.
October 28, 2024 | 12:38 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Kezar Life Sciences is conducting a 1-for-10 reverse stock split to meet Nasdaq's minimum bid price requirement. This move is aimed at maintaining its listing on the Nasdaq Capital Market.
The reverse stock split is a strategic move to increase the stock price and meet Nasdaq's listing requirements. While it doesn't change the company's market value, it can affect investor perception and trading activity.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100